The pertuzumab market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Pertuzumab is an antineoplastic recombinant monoclonal antibody that targets the human epidermal growth factor receptor 2 protein, often known as HER2. The medication inhibits the proliferation of human tumor cells by blocking signaling pathways that lead to cell growth […]
